Antibiotics and Antimalarials Without a Prescription in Africa: The Real Cost of the Counter

In much of sub-Saharan Africa, the pharmacy counter is the health system. A clinic visit means travel, queues and lost wages, so when a fever or a cough arrives, the practical move for millions is to walk into a drug shop and buy what worked last time. Antibiotics and antimalarials change hands this way every day, mostly without a prescription and often without a diagnosis. This is not a lecture about rule-breaking. It is an honest look at why the practice exists, what it genuinely costs, and what safer looks like within real constraints.

In short

• Studies pool to roughly 69 percent of pharmacy antibiotic requests in sub-Saharan Africa being supplied without a prescription, approaching 100 percent in some areas.
• Antimalarials are routinely dispensed without a confirmed malaria test, which wastes treatment on non-malaria fevers and delays the real diagnosis.
• The drivers are rational: cost, distance, queues and lost income, not ignorance.
• The bill arrives later as antimicrobial resistance: the drugs stop working region-wide, and resistant infections are already harder to treat.
• The highest-value habit is not "never buy at the counter"; it is test before treating malaria, and match the medicine to the illness rather than to memory.

Why is buying without a prescription so common?

Because for most people it is the rational choice: the pharmacy is nearby, immediate and affordable, while a formal consultation costs money, travel and a day's wages. Systematic reviews across the region, including a pooled analysis in Expert Review of Anti-infective Therapy, estimate around two-thirds of non-prescription antibiotic requests end in a sale, and in some rural settings virtually all do. Pharmacy staff face the same economics from the other side: refusing a sale sends the customer to the shop next door. Any honest discussion has to start from that reality rather than pretending the behaviour is careless.

What actually goes wrong with self-treated antibiotics?

The medicine is often wrong for the illness, the dose and duration are often wrong for the medicine, and every wrong exposure teaches bacteria to survive the next one. Most fevers, coughs and sore throats are viral, and an antibiotic like amoxicillin or azithromycin does nothing for them except cause side effects and train resistance. When the infection is bacterial, the counter choice is guided by what is remembered or cheapest, not by what the bacterium is susceptible to, and courses bought loose are frequently too short. We walk through the mechanics in the leftover antibiotics problem; the counter version is the same story at population scale. The regional consequence is resistance rates that are already among the world's most worrying for common drugs like ciprofloxacin.

What about malaria treatment without a test?

Treating every fever as malaria wastes antimalarials on the majority of fevers that are not malaria, and delays diagnosis of what the illness actually is. Studies such as this PMC analysis from Rwanda document antimalarials dispensed on request without a confirmed diagnosis. Rapid diagnostic tests now cost cents and give an answer in minutes, which changes the equation completely: a positive test means proper, full-course treatment for malaria; a negative test means the fever needs a different answer, sometimes urgently. Buying treatment without testing risks both, and it feeds resistance to the artemisinin combinations the region depends on. Presumptive self-treatment also masks dangerous look-alikes, from typhoid to pneumonia.

Isn't some access better than none?

Yes, and that is exactly why the useful advice is harm-reduction, not prohibition. Pharmacist-supplied treatment genuinely saves lives where clinics are out of reach, and several countries are formalising that role rather than fighting it: training drug-shop staff, licensing them to supply defined medicines properly, and putting rapid tests at the counter. For an individual, the practical rules that preserve most of the benefit while cutting most of the harm are:

• For fever, insist on a malaria rapid test before buying an antimalarial; a good pharmacy has one.
• Buy the full course, not the affordable half; a half course is the worst of both worlds.
• Describe the illness honestly and let the pharmacist match the medicine, rather than requesting last time's tablet by name.
• Buy from a licensed pharmacy, because the informal market is where falsified medicines concentrate; our guide to spotting fake medicines in West Africa covers that risk.
• Treat certain situations as non-negotiable clinic visits: infants, pregnancy, a fever that returns after treatment, or any severe symptoms.

The bottom line

Non-prescription antibiotics and antimalarials in Africa are a rational answer to a real access problem, and the cost of that answer is arriving as resistance that will hurt the same communities most. The realistic path is not scolding people toward clinics they cannot reach; it is testing before treating malaria, matching and completing courses, and buying from licensed sources. Every one of those steps is available at a good pharmacy counter today. Rules and services differ by country, so check what applies where you are.

This article is educational and does not replace advice from a doctor or pharmacist who knows your health history.